Mechanisms of PTEN-regulated PDK1 in modulating malignant phenotypes of clear cell renal cell carcinoma 【IF: 0】China Oncology. 2025 Sep 10;Issue (8): 761-768 Cell Counting Kit-8 purchased from AbMole
Patent. WO2025176679A1 【IF: 0】Patent. WO2025176679A1 2025 Aug 28; Crizotinib purchased from AbMole
Patent. US2025127716A1 【IF: 0】Patent. US2025127716A1 2025 Apr 24; Imatinib purchased from AbMole
Patent. CN119909067A 【IF: 0】Patent. CN119909067A 2025 May 02; D-Luciferin potassium salt purchased from AbMole
Patent. CN118388461B 【IF: 0】Patent. CN118388461B 2025 Feb 14; Cell Counting Kit-8 purchased from AbMole
Patent. CN119564831A 【IF: 0】Patent. CN119564831A 2025 Mar 07 MPP+ iodide purchased from AbMole
Patent. CN119639678A 【IF: 0】Patent. CN119639678A 2025 Mar 18 CHIR-99021 purchased from AbMole
Patent. CN119367339A 【IF: 0】Patent. CN119367339A 2025-01-28 Hypericin purchased from AbMole
Patent. CN119639678A 【IF: 0】Patent. CN119639678A 2025 Mar 18 Recombinant Human Noggin Protein (HEK293, C-His) purchased from AbMole
Patent. CN120536371A 【IF: 0】Patent. CN120536371A 2025 Aug 26; Y-27632 purchased from AbMole
Patent. CN120966886A 【IF: 0】Patent. CN120966886A 2025 Nov 18; DOTMA purchased from AbMole
Patent. WO2025229179A1 【IF: 0】Patent. WO2025229179A1 2025 Nov 06; SB939 purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
